
Jeffrey V Lazarus and John Dillon on steatotic liver disease
Failed to add items
Add to basket failed.
Add to Wish List failed.
Remove from Wish List failed.
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
By:
About this listen
In this episode, Senior Editor Ivana Nedic is joined by Prof Jeffrey V Lazarus and Prof John Dillon, leading experts in liver health, to discuss the urgent need to improve diagnosis and care for metabolic dysfunction-associated steatotic liver disease (MASLD) and its progressive form, MASH.
Building on insights from the recent Global Steatotic Liver Disease Think-Tank and a new health policy paper in The Lancet Regional Health – Europe, the conversation explores the disease's rising burden, diagnostic challenges, emerging therapies, and how health systems must adapt. With a focus on the social determinants of health, stigma and innovation, this episode offers a timely look at one of Europe’s fastest-growing and still under-recognised public health threats.
Read the full article:
https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(25)00112-7/fulltext?dgcid=buzzsprout_icw_podcast_July_25_lanepe